respiratori
infect
third
common
caus
death
mani
precipit
viral
infect
either
directli
damag
host
influenzaviru
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
indirectli
advers
effect
patient
condit
asthma
chronic
obstruct
pulmonari
diseas
cystic
world
health
organis
report
annual
influenza
epidem
result
estim
million
case
sever
ill
approxim
death
current
refer
standard
laboratori
test
influenza
diagnosi
quantit
revers
transcript
pcr
viral
uncommon
time
consum
expens
requir
specif
train
new
rapid
diagnost
test
forinfluenza
avail
show
sensit
specif
compar
pcr
figur
aim
systemat
review
literatur
determin
effect
test
influenza
outcom
patient
includ
use
antivir
influenza
viru
administr
antibiot
length
stay
lo
emerg
depart
ed
patient
present
symptom
acut
respiratori
infect
electron
databas
medlin
embas
independ
search
incept
decemb
review
report
accord
prefer
report
item
systemat
review
refer
includ
studi
recent
scientif
review
articl
influenza
test
poct
diagnost
manual
search
addit
relev
studi
includ
databas
search
strategi
creat
focu
term
influenza
point
care
test
combin
term
target
use
antivir
use
length
stay
specif
search
term
influenza
use
embas
includ
exp
influenza
mesh
exp
influenza
viru
mesh
explod
term
includ
type
influenza
well
differ
influenza
subtyp
search
term
test
includ
exp
point
care
test
mesh
exp
rapid
test
mesh
influenza
rapid
test
mesh
ridt
term
contain
subhead
includ
brand
name
commonli
use
commerci
poct
influenza
antibiot
antivir
compon
systemat
review
search
term
use
exp
antiviru
agent
mesh
exp
antivir
therapi
mesh
exp
antibiot
agent
mesh
exp
antibiot
therapi
mesh
search
term
use
length
stay
exp
length
stay
mesh
lo
search
term
medlin
influenza
exp
influenza
human
mesh
exp
orthomyoxvirida
mesh
search
term
test
includ
exp
point
care
test
mesh
exp
point
care
system
mesh
rapid
test
ridt
radt
influenza
rapid
test
search
term
antivir
exp
antivir
agent
mesh
oseltamivir
mesh
antivir
ther
antibiot
use
search
term
exp
agent
mesh
antibiot
antibacteri
search
term
use
length
stay
exp
length
stay
mesh
lo
two
review
gw
ssb
independ
screen
titl
abstract
articl
elig
use
criteria
supplement
addit
paper
search
manual
use
refer
suitabl
articl
case
uncertainti
elig
relev
particular
articl
resolut
achiev
consensu
review
exclud
scientif
review
articl
commentari
cochran
review
case
studi
case
seri
studi
analyt
model
studi
confer
abstract
studi
involv
survey
studi
publish
english
consid
studi
elig
inclus
assess
effect
poct
clinic
manag
patient
present
physician
hospit
acut
medic
centr
hous
visit
ill
ili
review
poct
defin
commerci
avail
diagnost
assay
detect
influenza
respiratori
sampl
test
consid
poct
need
conduct
immedi
specimen
acquisit
studi
specifi
test
perform
exclud
presum
done
point
care
test
commerci
avail
use
routin
influenza
diagnosi
immunosorb
assay
serolog
includ
definit
studi
use
refer
standard
viral
cell
cultur
nucleic
acid
test
immunofluoresc
diagnosi
base
patient
symptom
sign
elig
systemat
review
paper
exclud
result
poct
withheld
health
care
profession
use
diagnosi
attempt
made
contact
author
inform
data
lack
order
construct
tabl
search
perform
two
investig
separ
gw
ssb
qualiti
data
assess
two
investig
accord
oxford
centr
medicin
ocebm
paper
includ
systemat
review
elig
grade
level
ocebm
level
evid
consid
level
studi
excel
qualiti
level
good
level
fair
databas
search
yield
public
remov
duplic
figur
titl
abstract
screen
paper
assess
elig
addit
studi
found
citat
relev
public
assess
paper
full
text
assess
studi
method
outcom
total
met
select
criteria
includ
systemat
review
use
ocebm
level
evid
nine
studi
grade
level
excel
qualiti
grade
level
good
qualiti
nine
grade
level
fair
qualiti
tabl
found
support
inform
result
studi
differ
level
evid
examin
qualit
similar
trend
observ
studi
includ
studi
consist
retrospect
prospect
randomis
control
trial
poct
use
compos
techniqu
studi
method
includ
randomis
patient
poct
standard
care
comparison
preimplement
postimplement
poct
analysi
posit
neg
poct
result
patient
popul
review
includ
children
year
adult
year
wide
rang
studi
locat
includ
asia
australia
europ
north
america
public
measur
effect
poct
antivir
prescript
tabl
report
increas
antivir
use
associ
posit
diagnosi
poct
recent
randomis
control
trial
brendish
et
found
significantli
higher
prescript
rate
vs
p
amongst
studi
group
diagnos
poct
anoth
recent
studi
et
preimplement
postimplement
poct
show
increas
antivir
use
patient
vs
p
likewis
et
vs
p
blaschk
et
vs
p
jen
et
vs
vs
report
influenza
posit
patient
significantli
increas
antivir
use
amongst
diagnos
poct
compar
standard
test
blaschk
et
also
demonstr
antivir
prescript
significantli
higher
patient
receiv
posit
poct
result
comparison
neg
poct
result
vs
p
suryaprasad
et
vs
vs
theochari
et
vs
p
one
treatment
outcom
show
patient
prescrib
oseltamivir
significantli
like
diagnos
poct
compar
patient
receiv
antibiot
antibioticantivir
combin
support
care
two
studi
found
signific
effect
poct
antivir
studi
assess
effect
poct
antibiot
prescript
rate
tabl
eleven
compar
poct
standard
test
report
signific
decreas
antibiot
use
patient
receiv
influenza
posit
poct
diagnosi
addit
compar
poct
standard
test
three
also
assess
differ
posit
neg
poct
result
demonstr
patient
posit
influenza
poct
significantli
less
like
receiv
antibiot
eight
studi
report
similar
find
six
studi
found
signific
chang
antibiot
prescript
poct
nine
studi
assess
effect
poct
ed
length
stay
tabl
five
report
signific
reduct
time
spent
ed
associ
poct
use
trabattoni
et
vs
hour
p
abans
et
vs
hour
ci
demonstr
decreas
mean
ed
lo
prospect
studi
compar
poct
vs
standard
test
singl
influenza
season
similarli
two
retrospect
studi
compar
implement
soto
et
report
reduc
mean
ed
lo
vs
hour
p
roger
et
vs
hour
p
fernandez
et
also
demonstr
signific
decreas
ed
lo
case
poct
poct
patient
vs
hour
p
two
studi
found
signific
differ
ed
lo
poct
standard
test
whilst
two
studi
report
poct
increas
ed
lo
jeong
et
show
retrospect
studi
median
length
ed
stay
significantli
longer
systemat
implement
poct
vs
hour
p
whilst
jun
et
also
report
paediatr
mean
lo
significantli
longer
poct
use
vs
hour
p
first
systemat
review
examin
effect
use
current
commerci
avail
influenza
poct
diagnosi
prescript
antibiot
antivir
patient
lo
ed
diagnosi
influenza
posit
patient
poct
result
significantli
higher
rate
antivir
prescript
number
studi
compar
poc
standard
attribut
increas
antivir
use
faster
turnaround
time
diagnosi
poct
given
antivir
clinic
benefit
taken
within
hour
symptom
key
point
studi
compar
posit
neg
poct
result
increas
antivir
use
influenza
posit
patient
like
due
remov
diagnost
uncertainti
also
commonli
caus
patient
overprescrib
posit
result
may
elimin
unnecessari
antibiot
prescript
whilst
neg
poct
result
may
allow
bacteri
infect
treat
promptli
evid
studi
includ
review
demonstr
posit
poct
diagnosi
led
decreas
antibiot
use
compar
neg
poct
shorten
elimin
avoid
antibiot
use
benefit
reduc
risk
antibiot
resist
patient
level
length
stay
import
variabl
consid
evalu
effect
qualiti
patient
care
systemat
review
highlight
potenti
poct
influenza
reduc
ed
lo
howev
result
mix
two
studi
actual
report
poct
led
increas
lo
ed
jeong
et
attribut
longer
ed
stay
significantli
older
age
poct
cohort
may
comorbid
whilst
reason
studi
emerg
depart
lo
influenc
mani
factor
includ
avail
bed
overcrowd
admiss
discharg
procedur
effici
ed
staff
thu
may
benefit
poct
term
ed
lo
somewhat
diminish
reflect
mix
find
public
systemat
review
nonetheless
studi
find
reduc
ed
stay
associ
poct
encourag
lead
improv
clinic
outcom
prevent
nosocomi
spread
eas
burden
healthcar
system
signific
reduct
ed
lo
like
establish
monitor
health
care
centr
becom
familiar
poc
technolog
earli
poc
test
poor
term
sensit
quikvu
influenza
test
sensit
neg
predict
valu
physician
mani
case
awar
limit
use
confirmatori
test
avoid
nonetheless
find
studi
systemat
review
suggest
poct
still
significantli
affect
clinic
patient
outcom
newer
poct
boast
high
sensit
specif
mean
result
trust
physician
studi
use
newer
molecular
poct
saw
limit
effect
antibiot
prescript
rate
one
group
mani
case
antibiot
administ
earli
patient
assess
even
poct
result
avail
outcom
measur
proport
patient
treat
brief
cours
antibiot
may
clinic
relev
case
time
molecular
poct
perform
research
investig
rather
clinic
suggest
studi
protocol
initi
immedi
upon
ed
admiss
adopt
new
diagnost
technolog
requir
chang
manag
protocol
ed
collabor
order
maximis
benefit
improv
clinic
patient
workflow
paper
expand
upon
systemat
assess
effect
rapid
viral
diagnosi
children
acut
febril
respiratori
ill
rang
clinic
outcom
includ
antibiot
use
length
hospit
stay
previou
public
quantit
analysi
four
randomis
control
trial
wherea
systemat
review
qualit
analysi
studi
thu
abl
make
vastli
differ
conclus
find
similar
anoth
howev
review
differ
number
key
way
studi
ko
expert
opinion
studi
publish
januari
june
literatur
search
perform
pubm
specifi
criteria
select
studi
search
systemat
review
perform
two
databas
decemb
yield
differ
result
includ
six
recent
studi
use
poct
search
also
supplement
screen
citat
includ
public
relev
review
paper
addit
studi
meet
select
criteria
bias
due
corpor
interest
import
consider
review
literatur
potenti
benefit
poct
conflict
interest
statement
public
includ
systemat
review
thoroughli
check
two
declar
potenti
conflict
interest
financi
support
commerci
manufactur
poct
three
disclos
profession
relationship
contribut
author
compani
limit
systemat
review
focu
restrict
influenza
diagnosi
antivir
antibiot
lo
outcom
whilst
outcom
highli
applic
influenza
manag
new
molecular
poct
filmarray
respiratori
panel
test
rang
virus
bacteria
simultan
henc
technolog
potenti
affect
variabl
cover
review
area
may
target
futur
research
past
decad
numer
studi
report
divers
use
nanoparticl
poct
receiv
great
interest
uniqu
chemic
physic
sever
research
group
propos
simpl
colorimetr
approach
base
control
assembl
gold
nanoparticl
surfac
virus
includ
limit
detect
propos
method
time
lower
convent
immunosorb
report
repres
step
forward
develop
tool
facil
detect
surveil
influenza
virus
futur
integr
nanoparticl
specif
biolog
marker
facilit
next
gener
diagnost
method
detect
respiratori
virus
find
systemat
review
support
use
influenza
poct
patient
acut
respiratori
infect
major
studi
report
poct
associ
appropri
use
antivir
antibiot
lead
improv
health
outcom
patient
test
may
also
reduc
lo
ed
howev
clinic
trial
need
properli
assess
effect
rapid
diagnost
technolog
variabl
author
compet
interest
